Prime Medicine, Inc. (PRME)

NASDAQ: PRME · Real-Time Price · USD

3.240

-0.235 (-6.76%)

At close: Feb 5, 2026, 4:00 PM EST

3.350

+0.110 (3.40%)

Pre-market: Feb 6, 2026, 6:20 AM EST

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '20 Dec 31, 2020
Genetic Therapies	2.98M
Genetic Therapies Growth	-42.74%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '20 Dec 31, 2020
United States	2.98M
United States Growth	-42.74%